John Brooks

Senscio Systems, Inc. develops digital health solutions that provide information and support for consumers and clinicians. It offers Ibis solution, which provides a clinical safety net that enables care in the least restrictive setting for people with complex clinical, social, and behavioral conditions. The firm’s Ibis recognizes emerging health issues and care gaps in real time, provides self-care protocols, and alerts the care team to early intervention opportunities, avoiding the need for hospitalization using patent-pending artificial intelligence. The company was founded by Pilai De, Hugh Franklin Stoddart and Hugh A. Stoddart in 2010 and is headquartered in Boxborough, MA.

Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts.

Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products.

Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation.

Songbird Holdings LLC designs and manufactures hearing devices. Its products include songbird ultra, songbird ultra 2.0 replacement batteries, 2-pack ultra 2.0 right ear assembly and songbird air. The firm offers its products online, as well as through retailers. Songbird makes it as easy as buying a pair of new reading glasses. It provides a strong alternative to traditional hearing aids that can cost thousands of dollars. The company was founded in 2000 by Frederick J. Fritz and is headquartered in Tulsa, OK.

Confirma, Inc. develops and markets computer aided detection systems and accessories for medical imaging. The firm's products include CADstream, CADalog, and SureLoc. The company was founded in 1998 and is headquartered in Bellevue, WA.

The Charles Stark Draper Laboratory, Inc. engages in the design, development, and deployment of technological solutions. It focuses on the areas of commercial, space, national security, strategic systems, and global challenges. It provides engineering services to government, commercial companies, and educational institutions. The company was founded by Charles Stark Draper in 1934 and is headquartered in Cambridge, MA.

Harvard Cooperative Society is a leading food retailer with a focus on the convenience sector. The private company is based in Cambridge, MA. The group offers a wide range of additional services including funerals, insurance, legal services, and health. It champions a better way of doing business for customers and their communities. It is owned by millions of UK consumers and operates 2,600 food stores, over 1,000 funeral homes, and provides products to over 5,100 other stores, including those run by independent co-operative societies and through its wholesale business, Nisa Retail Limited. It has more than 63,000 colleagues and an annual revenue of over £10 billion.

Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA.

Pittsburgh Life Sciences Green House (PLSG) is a venture capital firm founded in 2002. The firm is headquartered in Pittsburgh, Pennsylvania.

Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers.

Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH.

Sharp Edge Labs, Inc. develops biosensors to the cellular biology research community. It operates as a assay development company that offers products and services for drug discovery. The firm offers fluorogenic activating protein, which provides accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and detailed follow-up. The company was founded by Alan S. Waggoner and Marcel P. Bruchez in 2010 and is headquartered in Pittsburgh, PA.

Reflectance Medical, Inc. develops medical devices. The company is based in Westborough, MA. Reflectance Medical was acquired by Sotera Wireless, Inc. on February 25, 2015.

T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018.

Population Health Alliance is a professional and trade association that has been advocating for population health management for over 20 years. The private company is based in Washington. The American company believes that applying the principles of population health improvement will lead to better health outcomes for all individuals and populations.

Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte.

Alertgy, Inc. engages in the development of a device for diabetes. Its product, Alerty GM, is a wristband that works with a mobile application to measure blood sugar. The company was founded by Marc E. Rippen and is headquartered in Melbourne, FL.

Ammonett Pharma LLC engages in pharmaceuticals industry. The company is headquartered in Midlothian, VA.

Theromics, Inc. is a medical device technology company that is developing a next-generation thermal accelerant technology for soft tissue ablation procedures and combination therapy. The company is based in West Bridgewater, MA. The company's proprietary heatsync™ gel is based on a protein naturally found in the body and may increase cost-efficiencies and improve outcomes through more focused and patient-centric delivery. The company will first focus on tumor ablations and then expand into additional applications, including pain and abnormal uterine bleeding. Longer-term, Theromics plans to apply its thermal technology for use as an oncolytic intratumoral drug/immunotherapy delivery platform with the potential to enhance efficacy and improve safety profiles of currently approved medicines. The company was founded by Damian E. Dupuy, William Keun Chan Park. The CEO is Ron Murphy.

NeuroBo Therapeutics, Inc. engages in the development and research of treatment for neurodegenerative diseases. It focuses on novel therapies for diabetic neuropathic pain and central nervous system diseases. The company was founded by Roy Freeman and is headquartered in Boston, MA.

Maroon Venture Partners LLC (Maroon Venture Partners) is a venture capital firm founded in 2016. The firm is headquartered in Amherst, Massachusetts.

L-Nutra, Inc. develops nutri-technologies that mimic the effects of fasting, to enhance the body?s natural ability to rejuvenate itself and promote longevity. The company was founded by Valter Longo and is headquartered in Los Angeles, CA.

Altrixbio, Inc. develops novel drugs that target metabolic diseases. The company is based in Cambridge, MA. The company was founded in 2019 by Ali Tavakkoli, Jeffrey Karp, Nancy Briefs. Nancy Briefs has been the CEO since 2019.

Atentiv LLC develops educational and digital learning tools. The company is based in Waltham, MA.

Basys.Ai LLC is a healthcare platform that utilizes generative AI to simplify prior authorization and utilization management. The platform promotes transparency and collaboration among healthcare insurers, providers, and other stakeholders to reduce administrative and medical costs and improve healthcare outcomes. The American company was founded by Amber Nigam and Jie Sun, with Amber Nigam serving as CEO since incorporation.

Cellnovo Group SA was a medical technology company, which specialized in diabetes. The company developed and marketed the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. It products portfolio included system, switch, pump therapy, and patient stories. The company was founded by Julian Shapley on December 15, 2014 and was headquartered in Paris, France.